Post-operative adjuvant thoracic radiotherapy for patients with completely resected no-small cell lung cancer with nodal involvement: Outcome and prognostic factors

British Journal of Radiology

Volumn 77, Issue 913, 2004, Pages 43-48

  Hsu, H C ^a   Wang, C J ^a   Huang, E Y ^a   Sun, L M ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; OBSERVER VARIATION; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS;

EID: 1242318805     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/21845347     Document Type: Article

References (29)

1. Emami B, Kaiser L, Simpson J, Shapiro S, Roper C, Lockett MA. Postoperative radiation therapy in non-small cell lung cancer. Am J Clin Oncol 1997;20:441-8.
2. Dautzenberg B, Arriagada R, Chammard AB, Jarema A, Mezzetti M, Mattson K, et al. A controlled study of post-operative radiotherapy for patients with completely resected nonsmall cell lung cancer. Cancer 1999;86:265-73.
3. Schield JW. Surgical therapy for carcinoma of the lung. Clin Chest Med 1993;14:121-47.
4. Rodrigus P. The impact of surgical adjuvant thoracic radiation for different stages of non-small cell lung cancer: the experience from a single institution. Lung Cancer 1999; 23:11-7.
5. Van HP, Rocmans P, Smets P. Postoperative radiation therapy in lung cancer. A controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys 1980;6:983-6.
6. Keller SM. Adjuvant therapy of resected non-small cell lung cancer. Curr Opin Oncol 2000;12:149-55.
7. Fleming ID, Cooper JS, Henson DE, et al. AJCC (American Joint Committee on Cancer) cancer staging manual (5th edn) Philadelphia: Lippincott, Williams & Wilkins, 1997:127-33.
8. Kaplan EL, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
9. Lawless JE. Statistical models and methods for lifetime data. New York: Wiley, 1982:420-2.
10. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
11. Henry WJ. Postoperative adjuvant therapy for patients with resected non-small cell lung cancer: still controversial after all these years. Chest 2000;117(Suppl):110-8.
12. Choi NC, Grillo HC, Gardiello M, Scannell JG, Wilkins EW. Basis of new strategies in postoperative radiotherapy of bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 1980; 6:31-5.
13. Green N, Kurohara SS, George FW, Crews QE. Postresection irradiation for primary lung cancer. Radiology 1975; 116:405-7.
14. PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomized controlled trials. Lancet 1998;352:257-63.
15. Medical Research Council Lung Cancer Working Party. Stephens RJ, Girling DJ, Bleehen NM, Moghissi K, Yosef HM, Machin D. The role of post-operative radiotherapy in non-small cell lung cancer multicentre randomized trial in patients with pathologically staged T1, N1-2, M0 disease. Br J Cancer 1996;74:632-9.
16. Sawyer TE, Bonner JA, Gould PM, Foote RL, Deschamps C, Trastek VF, et al. The impact of surgical adjuvant thoracic radiation therapy for patients with non-small cell lung carcinoma with ipsilateral mediastinal lymph node involvement. Cancer 1997;80:1399-408.
17. Le CT. Adjuvant chemotherapy in non-small cell lung cancer. Semin Oncol 1998;25:62-5.
18. Niiranen A, Niitamo-Korhonen S, Kouri M, Assendelft A, Mattson K, Pyrhonen S. Adjuvant chemotherapy after radical surgery for non-small cell lung cancer: a randomized study. J Clin Oncol 1992;10:1927-32.
19. Feld R, Rubinstein L, Thomas PA. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small cell lung cancer. J Natl Cancer Inst 1993;85:299-306.
20. The Study Group of Adjuvant Chemotherapy for Lung Cancer. A randomized trial of adjuvant postoperative chemotherapy in non-small cell lung cancer (the second cooperative study). Eur J Surg Oncol 1995;21:69-77.
21. Wada H, Hitomi S, Teramatsu T. Adjuvant chemotherapy after complete resection in non-small cell lung cancer. J Clin Oncol 1996;14:1048-54.
22. Holmes E, Gail M. Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma. J Clin Oncol 1986;4:710-5.
23. Figlin R, Piantadosi S. A phase 3 randomized trial of immediate combination chemotherapy vs. delayed combination chemotherapy in patients with completely resected Stage II and III non-small cell carcinoma of the lung. Chest 1994; 106:310-2.
24. Dautzenberg B, Chastang C, Arriagada R, Le Chevalier T, Belpomme D, Hurdebourcq M, et al. Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected non-small cell lung carcinoma. Cancer 1995;76:779-86.
25. Ohta M, Tsuchiya R, Shimoyama M, Sawamura K, Mori T, Miyazawa N, et al. Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer: results of a randomized prospective study. J Thorac Cardiovasc Surg 1993;106:703-8.
26. Lad T. The comparison of CAP chemotherapy and radiotherapy to radiotherapy alone for resected lung cancer with positive margin or involved highest sampled paratracheal node (stage IIIA). Chest 1994;106(Suppl):302S-6S.
27. Sorenson S, Glimelius B, Nygren P. A systematic overview of chemotherapy effects in non-small cell lung cancer. Acta Oncol 2001;40:327-39.
28. Keller SM, Adak S, Wagner H, Herskovic A, Komaki R, Brooks BJ, et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med 2000;343:1217-22.
29. Holmes E, Bleehen N, Le Chevalier T. Postoperative adjuvant treatments for non-small cell lung cancers: a consensus report. Lung Cancer 1991;7:11-3.